Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
2.
Int J Infect Dis ; 104: 379-381, 2021 Mar.
Article in English | MEDLINE | ID: covidwho-1385707

ABSTRACT

Microbiological response of SARS-CoV-2 to remdesivir in immunocompromised patients has not been evaluated. We present the case of a severely immunocompromised patient with persistent replication of SARS-CoV-2, who required different courses of remdesivir. Short courses of remdesivir might be insufficient in immunocompromised patients due to prolonged viral clearance.


Subject(s)
Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Antiviral Agents/administration & dosage , COVID-19 Drug Treatment , SARS-CoV-2/physiology , Virus Replication/drug effects , Adenosine Monophosphate/administration & dosage , Adult , Alanine/administration & dosage , COVID-19/diagnosis , COVID-19/virology , Female , Humans , Immunocompromised Host , SARS-CoV-2/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL